MedTrace Logo

South Danish Obesity Initiative, Screening for Unrecognized Obesity Related Disease

NCT05176132 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2700

Last updated 2023-10-19

No results posted yet for this study

Summary

People with BMI \>30 kg/m2 will be included in at population-based cohort. Additionally, one control group with BMI 18.5-25 kg/m2 and one control group with BMI 25-30 kg/m2 will be included. All participants with age 18 and 60 years.

To evaluate health status participants will be screened by for undetected obesity-related diseases (hypertension, diabetes, dyslipidemia, sleep apnea, non-alcoholic fatty liver disease, chronic obstructive pulmonary disease, EKG-abnormalities, polycystic ovary syndrome (PCOS), and joint pain and for quality of life at baseline, 1 year, and 5 years. Additionally, anthropometric measurements are collected and a biobank is established for future research studies.

People with obesity related disease will be offered participation in a 12 month personalized lifestyle intervention program aimed at improvement of health and self-perception.

The collected data will be used to detect the prevalence for obesity-related disease to identify predictors for future obesity related disease and to evaluate the effect of a lifestyle intervention on health and quality of life.

Conditions

Interventions

OTHER

Life style intervention (dietician+ physiotherapist)

Obese patients with obesity related diseases will be invited to participate in a personalized lifestyle intervention program with dieticians and physiotherapists focusing on health improvement through personal motivation and perceived limitations and body accept.

OTHER

Self management

Patients with no obesity related diseases will not be offered lifestyle intervention, but encouraged to physical activity (self management)

OTHER

No intervention

Control groups (BMI 20-25 and BMI 25-30)

Sponsors & Collaborators

  • Steno Diabetes Center Odense

    collaborator OTHER

  • Odense University Hospital

    collaborator OTHER

  • Claus Bogh Juhl

    lead OTHER

Principal Investigators

  • Claus B Juhl, Prof. PhD MD · Hospital South West Jutland, University hospital of Southern Denmark

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2025-09-01
Completion
2030-09-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05176132 on ClinicalTrials.gov